DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 160 filers reported holding DIPLOMAT PHARMACY INC in Q1 2016. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $33,000 | -38.9% | 8,204 | -25.9% | 0.00% | – |
Q3 2019 | $54,000 | -22.9% | 11,079 | -3.2% | 0.00% | – |
Q2 2019 | $70,000 | +150.0% | 11,444 | +138.4% | 0.00% | – |
Q1 2019 | $28,000 | -54.8% | 4,800 | +5.9% | 0.00% | – |
Q4 2018 | $62,000 | -29.5% | 4,534 | +0.6% | 0.00% | – |
Q3 2018 | $88,000 | -23.5% | 4,505 | -0.2% | 0.00% | – |
Q2 2018 | $115,000 | -13.5% | 4,516 | -31.5% | 0.00% | – |
Q1 2018 | $133,000 | +3.1% | 6,596 | +3.3% | 0.00% | – |
Q4 2017 | $129,000 | -10.4% | 6,388 | -8.7% | 0.00% | – |
Q3 2017 | $144,000 | -16.3% | 6,994 | -39.7% | 0.00% | – |
Q2 2017 | $172,000 | -4.4% | 11,600 | +3.0% | 0.00% | – |
Q1 2017 | $180,000 | +592.3% | 11,260 | +516.6% | 0.00% | – |
Q4 2016 | $26,000 | -54.4% | 1,826 | -9.9% | 0.00% | – |
Q3 2016 | $57,000 | -31.3% | 2,026 | -13.6% | 0.00% | – |
Q2 2016 | $83,000 | +25.8% | 2,346 | -3.1% | 0.00% | – |
Q1 2016 | $66,000 | -13.2% | 2,421 | +9.0% | 0.00% | – |
Q4 2015 | $76,000 | +162.1% | 2,221 | +122.1% | 0.00% | – |
Q3 2015 | $29,000 | -85.4% | 1,000 | -77.5% | 0.00% | – |
Q2 2015 | $199,000 | +17.8% | 4,450 | -9.2% | 0.00% | – |
Q1 2015 | $169,000 | – | 4,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |